Zangani Investor Community interviews Jason Gonzalez, Chief Executive Officer of Visual Management Systems (VMS). Jason discusses the company's recent acquisition of substantially all the assets of Intelligent Digital Systems, LLC., a leading enterprise surveillance software development company and manufacturer of the TechEye® Line of Network and Digital Video Recording Devices.

Visual Management Systems, Inc. (OTCBB: VMSY) is a New Jersey Based Corporation that consolidates the operations of subsidiaries including Visual Management Systems, LLC and Visual Management Systems PDG, LLC. The VMS Companies focus on providing businesses with remote management systems for loss prevention, physical security, asset protection and management controls - on and off-site.

Cleveland BioLabs, Inc. hosted a conference call today recapping recent achievements, as well as providing an update on the Company's development strategy and timeline.

Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. The Company has strategic partnerships with the Cleveland Clinic Foundation, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Research Radiobiology Institute.

Today Alseres Pharmaceuticals, Inc. hosted a conference call to reviewing the 2007 financial results and discuss other matters related to the Company.

Zangani interviews Harry S. Palmin, President and Chief Executive Officer of Novelos Therapeutics, Inc.

Mr. Palmin discusses Novelos' recent accomplishment of reaching the target enrollment of 840 patients in the pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) for its lead product NOV-002 in combination with first-line chemotherapy.

Javelin Pharmaceuticals, Inc. hosts a conference call, with Dr. Daniel B. Carr, CEO and CMO, and Stephen J. Tulipano, CPA, CFO, discussing the Company's annual results for the period ending December 31, 2007.

About Javelin Pharmaceuticals, Inc.:

Javelin is a specialty pharmaceutical company that applies proprietary technologies to develop new drugs and improved formulations of existing drugs for pain management. Specialty pharmaceutical analysts from six investment firms cover Javelin Pharmaceuticals, Inc. Javelin's headquarters are located in Cambridge, Massachusetts with European offices in Cambridge, England and Cologne, Germany. For additional information, visit www.javelinpharmaceuticals.com.

UTEK hosts a live conference call on Wednesday, March 5, 2008 at 10:00 a.m. EST to discuss its 2007 results.

About UTEK Corporation

UTEK® is an open innovation company focused on technology transfer. UTEK's services enable companies to acquire externally developed technologies from universities and research laboratories worldwide. In addition, UTEK provides services to help companies create value from their intellectual property. UTEK is a business development company with operations in the United States, United Kingdom and Israel. For more information about UTEK, please visit its website at www.utekcorp.com.

Zangani Investor Community interviews Jason Gonzalez, Chief Executive Officer of Visual Management Systems (VMS). Jason discusses the recent partnership with Sarku Japan, the largest Japanese quick-service food chain in the U.S., to develop and provide the corporate restauranteur networked CCTV systems for remote management and loss prevention.

Listen to Webcast Interview

Zangani Investor Community™ interviews Rhonda Greenapple, president & founder of Reimbursement Intelligence. Rhonda discusses how changes to the Medicare benefit impact utilization of biologics, injectables and other high cost products.

Listen to Webcast Interview

Learn how to help bring your product to approval.

Zangani Investor Community™ interviews Rhonda Greenapple, president & founder of Reimbursement Intelligence. Rhonda answers critical questions for all Biotech or specialty product organizations bringing a product to market.

Reimbursement Intelligence is a full-service consulting company that focuses on defining reimbursement strategies and business planning for biocapital companies.

Zangani Investor Community interviews Jason Gonzalez, Chief Executive Officer of Visual Management Systems (VMS). Jason discusses the recent placement investment of $3 million, as well as future growth strategies for VMS.

Today Alseres Pharmaceuticals, Inc. hosted a conference call to review the third quarter of 2007 and discuss other matters related to the Company.

Today Dr. Daniel B. Carr, CEO and CMO, and Stephen J. Tulipano, CPA, CFO, hosted a conference call discussing the Company's quarterly results for the period ending September 30, 2007.

Javelin Participants:

Dr. Daniel B. Carr, CEO and CMO; Fred Mermelstein, Ph.D., President; Stephen J. Tulipano, CPA, CFO; David B. Bernstein, Esq., General Counsel and Chief IP Counsel; Dr. Curtis Wright, IV, MPH, EVP, Risk Management and Regulatory Affairs and Rick Pierce, VP Investor Relations.

Zangani Investor Community(TM) interviews Rhonda Greenapple, president & founder of Reimbursement Intelligence. Rhonda provides an overview of the formulary process and answers critical questions for all biotech or specialty product organizations bringing a product to market. Listen in to learn how to help bring your product to approval.

Reimbursement Intelligence is a full-service consulting company that focuses on defining reimbursement strategies and business planning for biocapital companies.

Rodman & Renshaw and MedKnowledge present the latest in a series of medical expert conference calls.

Featuring Dr. Jay S. Skyler & Dr. Bernard Zinmam

The call was hosted by senior biotechnology analyst Michael G. King Jr., and Kelly L. Close, principal of Close Concerns, Inc.

Rodman & Renshaw and MedKnowledge present the latest in a series of medical expert conference calls.

Senior biotechnology analyst Michael G. King Jr. hosts the call, featuring E. Michael Lewiecki, MD .

Rodman & Renshaw and MedKnowledge present the latest in a series of medical expert conference calls.

Senior biotechnology analyst Michael G. King Jr. hosts the call, featuring Marc. A. Silver MD.

Javelin Pharmaceuticals CEO, Dr. Daniel B. Carr, provided a corporate overview at the recent BioCentury NewsMakers Conference in New York. Dr. Carr provided updates on the recent progress of Dyloject™ and PMI-150 (intranasal ketamine), two of Javelin's late stage pain care product candidates.

GeoPharma, Inc. hosted a conference call discussing results for the first fiscal quarter ended June 30, 2007 on Tuesday, August 14, 2007 at 11:30 a.m. (ET) with CEO, Mihir Taneja and VP/CFO, Carol Dore- Falcone. The Company has released the Company's operating results, available here:

GeoPharma Reports Q1 2008 Results

Zangani Investor Community(TM) interviews John B. Nano, Chairman, President and Chief Executive Officer of Competitive Technologies, Inc. John discusses CTT's recent acquisitions of pain management technology from Italy, as well as the current and future direction of Competitive Technologies along with their strategy in acquiring new technologies.

Mr. Nano is a graduate of MIT's Sloan School Executive Program, holds an MBA in Finance from Northeastern University, and a BS in Chemical Engineering from Worcester Polytechnic Institute.

UTEK Corporation held a live conference call to discuss its second quarter 2007 financial results.

About UTEK Corporation

UTEK® is a specialty finance company focused on technology transfer. UTEK's services enable companies to acquire innovative technologies from universities and research laboratories worldwide. UTEK facilitates the identification and acquisition of external technologies for clients in exchange for their equity securities. This unique process is called U2B®. In addition, UTEK offers companies the tools to search and analyze university intellectual properties. UTEK is a business development company with operations in the United States, United Kingdom and Israel. For more information about UTEK, please visit its website at www.utekcorp.com.